METADAP - Do Antidepressants Induce Metabolic Syndromes?
Head :
Corruble Emmanuelle, INSERM U669
CHU DE BICETRE - SERVICE DE PSYCHIATRIE
Last update : 07/09/2014 | Version : 1 | ID : 60183
| General | |
| Identification | |
| Detailed name | Do Antidepressants Induce Metabolic Syndromes? |
| Sign or acronym | METADAP |
| CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL |
| General Aspects | |
| Medical area |
Endocrinology and metabolism |
| Health determinants |
Intoxication |
| Others (details) | Metabolic syndromes |
| Keywords | criteria, definition, Health episodes, pharmacology, side effects |
| Scientific investigator(s) (Contact) | |
| Name of the director | Corruble |
| Surname | Emmanuelle |
| Address | 94275 LE KREMLIN BICETRE |
| Phone | + 33 (0)1 45 21 25 24 |
| emmanuelle.corruble@bct.aphp.fr | |
| Unit |
INSERM U669 CHU DE BICETRE - SERVICE DE PSYCHIATRIE |
| Organization | INSERM - Institut National de la Santé et de la Recherche |
| Collaborations | |
| Funding | |
| Funding status |
Public |
| Details | Ministère de la Santé (PHRC NATIONAL) |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | AP-HP |
| Organisation status |
Public |
| Additional contact | |
| Main features | |
| Type of database | |
| Type of database |
Study databases |
| Study databases (details) |
Cohort study |
| Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
| Database recruitment is carried out as part of an interventional study |
No |
| Additional information regarding sample selection. | Prospective Inclusion cut-off date: 01/11/2011 |
| Database objective | |
| Main objective | General objective: to assess the impact of antidepressants in terms metabolic syndromes. Secondary objective: to identify clinical, genetic and biological predictive factors concerning the onset of metabolic syndromes. |
| Inclusion criteria | Depressed patients requiring antidepressant treatment |
| Population type | |
| Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) |
| Population covered |
Sick population |
| Gender |
Male Woman |
| Geography area |
National |
| Detail of the geography area | Multicentric cohort throughout France (6 centres): 3 centres in the Paris region and 3 in the province. |
| Data collection | |
| Dates | |
| Date of first collection (YYYY or MM/YYYY) | 11/2007 |
| Size of the database | |
| Size of the database (number of individuals) |
< 500 individuals |
| Details of the number of individuals | 248 |
| Data | |
| Database activity |
Data collection completed |
| Type of data collected |
Clinical data Declarative data Biological data |
| Clinical data (detail) |
Direct physical measures Medical registration |
| Declarative data (detail) |
Paper self-questionnaire |
| Biological data (detail) | Type of samples taken: glucose level, cholesterol level, triglyceride level |
| Presence of a biobank |
Yes |
| Contents of biobank |
Serum Plasma DNA |
| Details of biobank content | Serum bank, plasma bank, DNA bank |
| Health parameters studied |
Health event/morbidity Health event/mortality |
| Procedures | |
| Data collection method | Self-administered questionnaire: direct input Interview: direct input Clinical examinations: direct input Biological analysis: direct input |
| Participant monitoring |
Yes |
| Details on monitoring of participants | Follow-up duration: 6 months |
| Links to administrative sources |
No |
| Promotion and access | |
| Promotion | |
| Link to the document | http://www.ncbi.nlm.nih.gov/pubmed/18707937 |
| Access | |
| Terms of data access (charter for data provision, format of data, availability delay) | To be decided if data may be used by academic teams To be decided if data may be used by industrial teams |
| Access to aggregated data |
Access on specific project only |
| Access to individual data |
Access on specific project only |
